Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin ten Haaf

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Public Health|February 6, 2026
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of VaudLouis Gros, Cynthia Schneider, May-Lucie Meyer, et al.
Thorax|April 1, 2017
Risk stratification based on screening history: the NELSON lung cancer screening studyUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
International Journal of Cancer|July 12, 2025
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling studyKoen de Nijs, Kevin Ten Haaf, Juul Hubert, et al.
JAMA Oncology|April 29, 2021
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant WomenGlen B Taksler, Elisabeth F P Peterse, Isarah Willems, et al.
Nature Communications|August 28, 2025
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trialsMax Welz, Carlijn M van der Aalst, Andreas Alfons, et al.
Annals of Internal Medicine|November 5, 2019
Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling StudySteven D Criss, Pianpian Cao, Mehrad Bastani, et al.
Thorax|October 30, 2021
Selection of eligible participants for screening for lung cancer using primary care dataEmma L O'Dowd, Kevin Ten Haaf, Jaspreet Kaur, et al.
JAMA|March 9, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task ForceRafael Meza, Jihyoun Jeon, Iakovos Toumazis, et al.
Journal of the National Cancer Institute|October 1, 2019
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening StrategiesKevin Ten Haaf, Mehrad Bastani, Pianpian Cao, et al.
Thorax|July 2, 2016
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening intervalUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Public Health|February 6, 2026
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of VaudLouis Gros, Cynthia Schneider, May-Lucie Meyer, et al.
Thorax|April 1, 2017
Risk stratification based on screening history: the NELSON lung cancer screening studyUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
International Journal of Cancer|July 12, 2025
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling studyKoen de Nijs, Kevin Ten Haaf, Juul Hubert, et al.
JAMA Oncology|April 29, 2021
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant WomenGlen B Taksler, Elisabeth F P Peterse, Isarah Willems, et al.
Nature Communications|August 28, 2025
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trialsMax Welz, Carlijn M van der Aalst, Andreas Alfons, et al.
Annals of Internal Medicine|November 5, 2019
Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling StudySteven D Criss, Pianpian Cao, Mehrad Bastani, et al.
Thorax|October 30, 2021
Selection of eligible participants for screening for lung cancer using primary care dataEmma L O'Dowd, Kevin Ten Haaf, Jaspreet Kaur, et al.
JAMA|March 9, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task ForceRafael Meza, Jihyoun Jeon, Iakovos Toumazis, et al.
Journal of the National Cancer Institute|October 1, 2019
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening StrategiesKevin Ten Haaf, Mehrad Bastani, Pianpian Cao, et al.
Thorax|July 2, 2016
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening intervalUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
Pageof 6